{"count": 7, "results": [{"_id": "33232684", "pmid": 33232684, "pmcid": "PMC7586924", "title": "Metformin is Associated with Decreased 30-Day Mortality Among Nursing Home Residents Infected with SARS-CoV2", "journal": "J Am Med Dir Assoc", "authors": ["Lally MA", "Tsoukas P", "Halladay CW", "O'Neill E", "Gravenstein S", "Rudolph JL"], "date": "2021-01-01T00:00:00Z", "doi": "10.1016/j.jamda.2020.10.031", "meta_date_publication": "2021 Jan", "meta_volume": "22", "meta_issue": "1", "meta_pages": "193-198", "score": 50274.754, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ is Associated with Decreased 30-Day @DISEASE_Death @DISEASE_MESH:D003643 @@@Mortality@@@ Among Nursing Home Residents Infected with @<m>DISEASE_Severe_Acute_Respiratory_Syndrome</m> @DISEASE_MESH:D045169 @@@SARS-CoV2@@@", "citations": {"NLM": "Lally MA, Tsoukas P, Halladay CW, O'Neill E, Gravenstein S, Rudolph JL. Metformin is Associated with Decreased 30-Day Mortality Among Nursing Home Residents Infected with SARS-CoV2 J Am Med Dir Assoc. 2021 Jan;22(1):193-198. PMID: 33232684", "BibTeX": "@article{33232684, title={Metformin is Associated with Decreased 30-Day Mortality Among Nursing Home Residents Infected with SARS-CoV2}, author={Lally MA and Tsoukas P and Halladay CW and O'Neill E and Gravenstein S and Rudolph JL}, journal={J Am Med Dir Assoc}, volume={22}, number={1}, pages={193-198}}"}}, {"_id": "35370738", "pmid": 35370738, "pmcid": "PMC8964397", "title": "Diabetes, Metformin and the Clinical Course of Covid-19: Outcomes, Mechanisms and Suggestions on the Therapeutic Use of Metformin", "journal": "Front Pharmacol", "authors": ["Bailey CJ", "Gwilt M"], "date": "2022-03-09T00:00:00Z", "doi": "10.3389/fphar.2022.784459", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "784459", "score": 50263.043, "text_hl": "Studies on the effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on outcomes in people infected with @DISEASE_COVID_19 @DISEASE_MESH:D000086382 @@@Covid-19@@@ were identified by searching PubMed using the following search string: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ AND (@DISEASE_COVID_19 @DISEASE_MESH:D000086382 @@@covid@@@ [ti] OR @DISEASE_COVID_19 @DISEASE_MESH:D000086382 @@@covid-19@@@ [ti] OR @DISEASE_COVID_19 @DISEASE_MESH:D000086382 @@@covid19@@@ [ti] OR @DISEASE_Coronavirus_Infections @DISEASE_MESH:D018352 @@@coronavirus@@@ [ti] OR @<m>DISEASE_Severe_Acute_Respiratory_Syndrome</m> @DISEASE_MESH:D045169 @@@SARS-Cov2@@@ [ti]), and @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ AND (@DISEASE_COVID_19 @DISEASE_MESH:D000086382 @@@covid@@@ OR @DISEASE_COVID_19 @DISEASE_MESH:D000086382 @@@covid-19@@@ OR @DISEASE_COVID_19 @DISEASE_MESH:D000086382 @@@covid19@@@ OR @DISEASE_Coronavirus_Infections @DISEASE_MESH:D018352 @@@coronavirus@@@ [ti] OR @<m>DISEASE_Severe_Acute_Respiratory_Syndrome</m> @DISEASE_MESH:D045169 @@@SARS-Cov2@@@ [ti]); the second search was limited to \"Clinical Study, Clinical Trial, Controlled Clinical Trial, Meta-Analysis, Observational Study, Randomized Controlled Trial, and Systematic Review\" to exclude general reviews and limit the number of search hits. ", "citations": {"NLM": "Bailey CJ, Gwilt M. Diabetes, Metformin and the Clinical Course of Covid-19: Outcomes, Mechanisms and Suggestions on the Therapeutic Use of Metformin Front Pharmacol. 2022;13():784459. PMID: 35370738", "BibTeX": "@article{35370738, title={Diabetes, Metformin and the Clinical Course of Covid-19: Outcomes, Mechanisms and Suggestions on the Therapeutic Use of Metformin}, author={Bailey CJ and Gwilt M}, journal={Front Pharmacol}, volume={13}, pages={784459}}"}}, {"_id": "35325361", "pmid": 35325361, "pmcid": "PMC8944405", "title": "The Risk Factors Potentially Influencing Hospital Admission in People with Diabetes, Following SARS-CoV-2 Infection: A Population-Level Analysis", "journal": "Diabetes Ther", "authors": ["Heald AH", "Jenkins DA", "Williams R", "Sperrin M", "Fachim H", "Mudaliar RN", "Syed A", "Naseem A", "Gibson JM", "Bowden Davies KA", "Peek N", "Anderson SG", "Peng Y", "Ollier W"], "date": "2022-05-01T00:00:00Z", "doi": "10.1007/s13300-022-01230-2", "meta_date_publication": "2022 May", "meta_volume": "13", "meta_issue": "5", "meta_pages": "1007-1021", "score": 50248.61, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ prescription lowered the likelihood. ", "citations": {"NLM": "Heald AH, Jenkins DA, Williams R, Sperrin M, Fachim H, Mudaliar RN, Syed A, Naseem A, Gibson JM, Bowden Davies KA, Peek N, Anderson SG, Peng Y, Ollier W. The Risk Factors Potentially Influencing Hospital Admission in People with Diabetes, Following SARS-CoV-2 Infection: A Population-Level Analysis Diabetes Ther. 2022 May;13(5):1007-1021. PMID: 35325361", "BibTeX": "@article{35325361, title={The Risk Factors Potentially Influencing Hospital Admission in People with Diabetes, Following SARS-CoV-2 Infection: A Population-Level Analysis}, author={Heald AH and Jenkins DA and Williams R and Sperrin M and Fachim H and Mudaliar RN and Syed A and Naseem A and Gibson JM and Bowden Davies KA and Peek N and Anderson SG and Peng Y and Ollier W}, journal={Diabetes Ther}, volume={13}, number={5}, pages={1007-1021}}"}}, {"_id": "37653675", "pmid": 37653675, "title": "Promising translatable pharmacological interventions for body weight management in individuals with severe mental illness - a narrative review.", "journal": "Expert Opin Pharmacother", "authors": ["De R", "Prasad F", "Stogios N", "Burin L", "Ebdrup BH", "Knop FK", "Hahn MK", "Agarwal SM"], "date": "2023-08-31T00:00:00Z", "doi": "10.1080/14656566.2023.2254698", "meta_date_publication": "2023 Aug 31", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50242.418, "text_hl": "AREAS COVERED: A literature search was conducted including agents approved for the management of @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obesity@@@ in the general population, along with upcoming agents under investigation in phase III trials with @DISEASE_Weight_Loss @DISEASE_MESH:D015431 @@@weight loss@@@ properties. EXPERT OPINION: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and @CHEMICAL_Topiramate @CHEMICAL_MESH:D000077236 @@@topiramate@@@ along with lifestyle interventions are commonly prescribed for @DISEASE_Weight_Gain @DISEASE_MESH:D015430 @@@weight gain@@@ in individuals with @<m>DISEASE_Severe_Acute_Respiratory_Syndrome</m> @DISEASE_MESH:D045169 @@@SMI@@@; however, their @DISEASE_Weight_Loss @DISEASE_MESH:D015431 @@@weight loss@@@ potential is modest at best. ", "citations": {"NLM": "De R, Prasad F, Stogios N, Burin L, Ebdrup BH, Knop FK, Hahn MK, Agarwal SM. Promising translatable pharmacological interventions for body weight management in individuals with severe mental illness - a narrative review. Expert Opin Pharmacother. 2023 Aug 31;():. PMID: 37653675", "BibTeX": "@article{37653675, title={Promising translatable pharmacological interventions for body weight management in individuals with severe mental illness - a narrative review.}, author={De R and Prasad F and Stogios N and Burin L and Ebdrup BH and Knop FK and Hahn MK and Agarwal SM}, journal={Expert Opin Pharmacother}}"}}, {"_id": "32475838", "pmid": 32475838, "pmcid": "PMC7265016", "title": "Long-term changes in carbohydrate tolerance, insulin secretion and action in African-American patients with obesity and history of hyperglycemic crises", "journal": "BMJ Open Diabetes Res Care", "authors": ["Vellanki P", "Stefanovski D", "Anzola II", "Smiley DD", "Peng L", "Umpierrez GE"], "date": "2020-05-01T00:00:00Z", "doi": "10.1136/bmjdrc-2019-001062", "meta_date_publication": "2020 May", "meta_volume": "8", "meta_issue": "1", "meta_pages": "", "score": 50233.258, "text_hl": "Seventy-five participants with @DISEASE_Diabetic_Ketoacidosis @DISEASE_MESH:D016883 @@@DKA@@@ (n=33) and @<m>DISEASE_Severe_Acute_Respiratory_Syndrome</m> @DISEASE_MESH:D045169 @@@SH@@@ (n=42) underwent 2-hour 75 g oral @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@ tolerance test (OGTT) after @GENE_INS @GENE_3630 @@@insulin@@@ discontinuation and every 6 months until @DISEASE_Hyperglycemia @DISEASE_MESH:D006943 @@@hyperglycemia@@@ relapse (FBG >=130 mg/dL, HbA1c >7% or two random BG >=180 mg/dL) while treated with @DISEASE_Dyskinesias @DISEASE_MESH:D020820 @@@OAD@@@ (@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, @CHEMICAL_Sitagliptin_Phosphate @CHEMICAL_MESH:D000068900 @@@sitagliptin@@@ or @CHEMICAL_Pioglitazone @CHEMICAL_MESH:D000077205 @@@pioglitazone@@@) or placebo. ", "citations": {"NLM": "Vellanki P, Stefanovski D, Anzola II, Smiley DD, Peng L, Umpierrez GE. Long-term changes in carbohydrate tolerance, insulin secretion and action in African-American patients with obesity and history of hyperglycemic crises BMJ Open Diabetes Res Care. 2020 May;8(1):. PMID: 32475838", "BibTeX": "@article{32475838, title={Long-term changes in carbohydrate tolerance, insulin secretion and action in African-American patients with obesity and history of hyperglycemic crises}, author={Vellanki P and Stefanovski D and Anzola II and Smiley DD and Peng L and Umpierrez GE}, journal={BMJ Open Diabetes Res Care}, volume={8}, number={1}}"}}, {"_id": "29480037", "pmid": 29480037, "title": "Pharmacological management of diabetes in severe mental illness: a comprehensive clinical review of efficacy, safety and tolerability.", "journal": "Expert Rev Clin Pharmacol", "authors": ["Lally J", "O' Loughlin A", "Stubbs B", "Guerandel A", "O'Shea D", "Gaughran F"], "date": "2018-04-01T00:00:00Z", "doi": "10.1080/17512433.2018.1445968", "meta_date_publication": "2018 Apr", "meta_volume": "11", "meta_issue": "4", "meta_pages": "411-424", "score": 50055.02, "text_hl": "The first line therapeutic option for @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2DM@@@ in @<m>DISEASE_Severe_Acute_Respiratory_Syndrome</m> @DISEASE_MESH:D045169 @@@SMI@@@ for which there is most evidence is @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Lally J, O' Loughlin A, Stubbs B, Guerandel A, O'Shea D, Gaughran F. Pharmacological management of diabetes in severe mental illness: a comprehensive clinical review of efficacy, safety and tolerability. Expert Rev Clin Pharmacol. 2018 Apr;11(4):411-424. PMID: 29480037", "BibTeX": "@article{29480037, title={Pharmacological management of diabetes in severe mental illness: a comprehensive clinical review of efficacy, safety and tolerability.}, author={Lally J and O' Loughlin A and Stubbs B and Guerandel A and O'Shea D and Gaughran F}, journal={Expert Rev Clin Pharmacol}, volume={11}, number={4}, pages={411-424}}"}}, {"_id": "31856432", "pmid": 31856432, "title": "Effectiveness of Pharmacologic Interventions in the Management of Weight Gain in Patients With Severe Mental Illness: A Systematic Review and Meta-Analysis.", "journal": "Prim Care Companion CNS Disord", "authors": ["Hiluy JC", "Nazar BP", "Gonçalves WS", "Coutinho W", "Appolinario JC"], "date": "2019-12-19T00:00:00Z", "doi": "10.4088/PCC.19r02483", "meta_date_publication": "2019 Dec 19", "meta_volume": "21", "meta_issue": "6", "meta_pages": "", "score": 50048.492, "text_hl": "CONCLUSIONS: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and @CHEMICAL_Topiramate @CHEMICAL_MESH:D000077236 @@@topiramate@@@ were the most-studied agents for weight control in @<m>DISEASE_Severe_Acute_Respiratory_Syndrome</m> @DISEASE_MESH:D045169 @@@SMI@@@ and were considered efficacious and safe in promoting weight reduction compared to placebo in this population. ", "citations": {"NLM": "Hiluy JC, Nazar BP, Gonçalves WS, Coutinho W, Appolinario JC. Effectiveness of Pharmacologic Interventions in the Management of Weight Gain in Patients With Severe Mental Illness: A Systematic Review and Meta-Analysis. Prim Care Companion CNS Disord. 2019 Dec 19;21(6):. PMID: 31856432", "BibTeX": "@article{31856432, title={Effectiveness of Pharmacologic Interventions in the Management of Weight Gain in Patients With Severe Mental Illness: A Systematic Review and Meta-Analysis.}, author={Hiluy JC and Nazar BP and Gonçalves WS and Coutinho W and Appolinario JC}, journal={Prim Care Companion CNS Disord}, volume={21}, number={6}}"}}]}